Genentech’s Hillsboro Oregon campus—Hillsboro Innovative Therapies (HIT)—serves as a critical hub for emerging cell & gene therapy manufacturing. Housed within a modern 75-acre facility just outside Portland, HIT is at the forefront of advancing cell and gene therapy medicines through accelerated clinical and commercial manufacturing capabilities, aligning with Genentech’s mission to bring transformative therapies to patients. This role is a part of our Quality Systems and Validation (QSV) team, which is dedicated to supporting the design, startup, and operation of a cutting-edge GMP facility. As a member of this team, you will collaborate closely with stakeholders across Clinical Facilities, Technical Development, and Global Quality to define and implement robust Quality Systems, Validation strategies, and automated QC methods that ensure compliance with cGMP regulations and enable instantaneous product disposition. You will play a pivotal role in driving innovation, fostering a continuous improvement mindset, and shaping processes for next-generation production in a dynamic and engaging environment. The Opportunity: As the Head of QSV, you will serve as a pivotal strategic architect, designing and orchestrating a world-class QSV framework for a cutting-edge, high-throughput GMP manufacturing facility. This is not merely a compliance role; it is a leadership mandate to bridge the gap between innovative engineering and regulatory excellence. You will act as a primary influencer across the global network, harmonizing complex stakeholder interests to enable rapid product disposition and next-generation production goals. Key strategic responsibilities include: